Run by Cedars-Sinai.
A twelve-month Los Angeles programme for Seed+ and late-seed healthcare companies, spanning healthtech and medtech. Capital investment is part of the offer, but the amount is not published on the programme site, and no equity stake is stated either.
This programme has notes explaining its undisclosed figures, available in the full dataset.
Every figure above is taken from these pages, published by the programme or its parent organisation.
Last verified 2026-09-05.